Is STNRF or JNJ a better dividend investment in 2026?

STNRF currently yields 3676.47% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: STNRF offers higher current income.

What is the dividend yield difference between STNRF and JNJ?

STNRF has a forward dividend yield of 3676.47% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 3674.34 percentage points.

Home › Compare › STNRF vs JNJ

STNRF vs JNJ: Dividend Comparison 2026

STNRF yields 3676.47% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 STNRF wins by $3185191696693.22M in total portfolio value

INVESTMENT

TIME HORIZON10 years

STNRF

● Live price

3676.47%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3185191696693.25M

Annual income

$3,023,419,072,917,171,000.00

Full STNRF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — STNRF vs JNJ

📍 STNRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	STNRF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, STNRF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

STNRF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STNRF

Annual income on $10K today (after 15% tax)

$312,500.00/yr

After 10yr DRIP, annual income (after tax)

$2,569,906,211,979,595,300.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, STNRF beats the other by $2,569,906,211,979,591,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STNRF + JNJ for your $10,000?

STNRF: 50%JNJ: 50%

100% JNJ50/50100% STNRF

Portfolio after 10yr

$1592595848346.64M

Annual income

$1,511,709,536,458,588,000.00/yr

Blended yield

94.92%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

STNRF

No analyst data

Altman Z

228.2

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STNRF buys

JNJ buys

No recent congressional trades found for STNRF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSTNRFJNJ

Forward yield	3676.47% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$3185191696693.25M ✓	$30.3K
Annual income after 10y	$3,023,419,072,917,171,000.00 ✓	$4,689.40
Total dividends collected	$3174116937882.48M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: STNRF vs JNJ ($10,000, DRIP)

Year	STNRF Portfolio	STNRF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$378,347	$367,647.06	$10,592	$272.30	+$367.8K → STNRF
2	$13,404,662	$12,999,830.22	$11,289	$357.73	+$13.39M → STNRF
3	$444,789,700	$430,446,711.77	$12,123	$472.89	+$444.78M → STNRF
4	$13,824,487,019	$13,348,562,040.26	$13,141	$629.86	+$13824.47M → STNRF
5	$402,536,133,306	$387,743,932,195.94	$14,408	$846.81	+$402536.12M → STNRF
6	$10,982,283,507,861	$10,551,569,845,223.72	$16,021	$1,151.60	+$10982283.49M → STNRF
7	$280,793,661,559,725	$269,042,618,206,312.97	$18,122	$1,588.22	+$280793661.54M → STNRF
8	$6,729,279,374,455,215	$6,428,830,156,586,310.00	$20,930	$2,228.20	+$6729279374.43M → STNRF
9	$151,189,368,015,029,540	$143,989,039,084,362,480.00	$24,792	$3,191.91	+$151189368015.00M → STNRF
10	$3,185,191,696,693,252,600	$3,023,419,072,917,171,000.00	$30,274	$4,689.40	+$3185191696693.22M → STNRF

STNRF vs JNJ: Complete Analysis 2026

STNRF — Stock

Stinger Resources Inc. is engaged in the exploration and development of mineral properties in Canada. The company holds 100% interests in the Dunwell Mine property located near Stewart, British Columbia; and the Gold Hill property located near Fort Steele, British Columbia. It also holds interests in the Ample Goldmax property located near Lillooet, British Columbia; the Silverside property located near Clearwater, British Columbia; the Glitter King property located in Pitt Island, British Columbia; and holds 100% in the D-1 McBride property located near Dease Lake, British Columbia. The company was incorporated in 2020 and is headquartered in Cardston, Canada.

Full STNRF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this STNRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STNRF vs SCHD STNRF vs JEPI STNRF vs O STNRF vs KO STNRF vs MAIN STNRF vs ABBV STNRF vs MRK STNRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.